Multisite study for genotyping of the factor II (prothrombin) G20210A mutation by the invader assay.
نویسندگان
چکیده
References 1. Sunderman FW. The clinical biochemistry of 59-nucleotidase [Review]. Ann Clin Lab Sci 1990;20:123–39. 2. Bodansky O, Schwartz MK. 59-Nucleotidase [Review]. Adv Clin Chem 1968; 11:277–328. 3. Dixon TF, Purdom M. Serum 59-nucleotidase. J Clin Pathol 1954;7:341–3. 4. Eshchar J, Rudzki C, Zimmerman HJ. Serum levels of 59-nucleotidase in disease. Am J Clin Pathol 1967;47:598–606. 5. Belfield A, Goldberg DM. Application of a continuous spectrophotometric assay for 59nucleotidase activity in normal subjects and patients with liver and bone disease. Clin Chem 1969;15:931–9. 6. Goldberg DM. 59-Nucleotidase: recent advances in cell biology, methodology and clinical significance [Review]. Digestion 1973;8:87–99. 7. Reichling JJ, Kaplan MM. Clinical use of serum enzymes in liver disease [Review]. Dig Dis Sci 1988;33:1601–14. 8. Phelan MB, Neale G, Moss DW. Serial studies of serum alkaline phosphatase and 59-nucleotidase levels in hepatobiliary disease. Clin Chim Acta 1971;32:95–102. 9. Belfield A. Serum alkaline phosphatase and 59-nucleotidase activities in patients with hepatobiliary disease. Clin Chim Acta 1972;37:525–9. 10. Ellis G, Goldberg DM, Spooner RJ, Ward AM. Serum enzyme tests in diseases of the liver and biliary tree. Am J Clin Pathol 1978;70:248–58. 11. Novo FJ, Tutor JC. Changes in alkaline phosphatase and 59-nucleotidase multiple forms after surgical management of biliary obstruction. Clin Chem 1992;38:1340–2. 12. Panteghini M. Electrophoretic fractionation of 59-nucleotidase. Clin Chem 1994;40:190–6. 13. Panteghini M. Hepatic alkaline phosphatase isoenzyme. II. Clinical aspects [Review]. G Ital Chim Clin 1990;15:301–8. 14. Pagani F, Panteghini M. Biological variation in serum activities of three hepatic enzymes [Letter]. Clin Chem 2001;47:355–6. 15. Moss DW, Henderson AR. Biliary tract enzymes. In: Burtis CA, Ashwood ER, eds. Tietz textbook of clinical chemistry, 2nd ed. Philadelphia: WB Saunders, 1994:843–51.
منابع مشابه
Factor V Leiden, MTHFR C677T and Prothrombin Gene Mutation G20210A in Iranian Patients with Venous Thrombosis
Background: Factor V Leiden, Prothrombin gene (G20210A) and MTHFR (C677T) polymorphism are the main biomarkers for evaluation of tendency for venous thromboembolism. We aimed to investigate the frequency of mutations in factor V Leiden, Prothrombin G20210A and MTHFR C677T and identify the genetic status for these mutations in patients with venous thrombosis. Methods: This study was carried out...
متن کاملFrequency of factor V Leiden (G1691A) and prothrombin (G20210A) polymorphisms in Population of Kerman Province, Iran
Background & Aims:Thromboembolism is an acute cardiovascular disease that ranges from clinically unimportant to massive embolism. Both acquired and hereditary risk factors contribute to the disease. We aimed to determine the prevalence of two hereditary predisposing factor of the disease, prothrombin G20210A and factor V Leiden (G1691A) polymorphisms, in Kerman population.<br /...
متن کاملFrequency of Factor V Leiden and Prothrombin Polymorphism in South of Iran
Normal hemostasis requires balanced regulation of prothrombotic and antithrombotic factors. Inherited alteration of factor V and prothrombin gene, the G20210A mutation, increases the resistance of factor V to degradation and booster production of prothrombin respectively. These alterations can increase hypercoagulability leading to thrombotic consequences. We aimed to assess the frequencies of ...
متن کاملScreening of Factor V G1691A (Leiden) and Factor II/prothrombin G20210A Polymorphisms among Apparently Healthy Taif-Saudi Arabia Population Using a Reverse Hybridization Strip Assay Approach
Single nucleotide polymorphisms (SNPs) Factor V G1691A and Factor II G20210A have been shown to play a role in both venous and arterial thrombosis. Several studies have been carried out to estimate the prevalence of Factor V G1691A and the Factor II/prothrombin G20210A gene polymorphisms among healthy subjects. The aim of the present work is to study the prevalence and allele frequency of facto...
متن کاملThe Association between Preeclampsia and Defined Polymorphisms in Prothrombin and Coagulation Factor V Genes
Background & Aims: Preeclampsia is one of the complications of pregnancy and a major cause of maternal mortality. Since, hypercoagulation is one of the risk factors, defined polymorphisms of V and II coagulation factors (G1691A and G20210A) may increase the risk of the disease. Methods: This investigation was performed on blood samp...
متن کاملشیوع ﭘﻠﻲﻣﻮرﻓﻴﺴﻢ پروترومبین G20210A در جنوب ایران
Background: There are many genetic and non-hereditary risk factors that are known to causes venous thromboembolic (VTE) disorders, Cardiovascular diseases and types of cancer. One of these is the Prothrombin G20210A mutation. Prothrombin mutation (guanine to adenine G→A) at nucleotide position 20210, which is present in the 3′ untranslated region of the prothrombin gene. Prothrombin G20210A mut...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Clinical chemistry
دوره 47 11 شماره
صفحات -
تاریخ انتشار 2001